Puma Biotechnology PBYI
NASDAQ PBYI
$8.08 -0.06 (-0.74%)
At close: Nov 11, 2026 · 4:00 PM EST

Puma Biotechnology (PBYI) Gains from Sales and Divestitures (2019 - 2026)

Updated

Puma Biotechnology's Gains from Sales and Divestitures was -$6,000 in Q1 2026.

Analysis

Puma Biotechnology (PBYI) Gains from Sales and Divestitures (2019 - 2026) Analysis & Trends

For FY2025, Gains from Sales and Divestitures at Puma Biotechnology came in at -$4,000.

  • In earlier years, Gains from Sales and Divestitures was -$1,000 in FY2022 and -$1,000 in FY2021.
  • The Q1 2026 figure marks the lowest quarterly Gains from Sales and Divestitures since Q2 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Puma Biotechnology 420.82 Mn 19.27 Mn 39.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -6,000.00
Sep 30, 2025 -4,000.00
Mar 31, 2022 -1,000.00
Dec 31, 2021 -1,000.00
Jun 30, 2019 -53,000.00
Mar 31, 2019 -1,000.00
API Access

Puma Biotechnology Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=PBYI&period=max&api_key=YOUR_API_KEY